Imageens Announces Partnership with WOMIA

Paris, 14.02.2024 — Imageens and Womia, a HealthTech startup dedicated to accessible cardiovascular prevention, proudly announce their strategic partnership aimed at transforming cardiovascular risk assessment through artificial intelligence.

Officially established earlier this year, this partnership combines complementary expertise in AI-powered medical imaging, clinical workflow integration, and healthcare delivery tailored to underserved markets. A key milestone in their collaboration is the launch of a multicenter pilot deployment of CardioInspect — Imageens’s flagship platform for advanced cardiovascular risk stratification, powered by its proprietary imaging biomarker technology.

“Our partnership with Imageens is founded on a shared vision to democratize precision cardiovascular prevention and make it accessible across the Middle East and Africa,” said Dr. Sabrine Aidi-Knani, CEO of Womia.

“We are proud to collaborate closely with Womia to extend the reach of our AI-powered imaging biomarkers where the need is greatest,” added Dr. Anas Dogui, CEO of Imageens. “Together, we are bridging cutting-edge research and real-world clinical impact in cardiovascular health.”

---

About Womia

Womia is a HealthTech startup focused on democratizing access to AI-driven cardiovascular prevention. With deep scientific roots and strong clinical partnerships, Womia aims to bring high-quality, proactive care to underserved populations in emerging markets, starting in the MEA region.

About Imageens

Imageens is a Paris-based HealthTech company founded in 2017, focused on the prevention and early diagnosis of cardiovascular diseases through AI-powered imaging biomarkers.